In Depth 26 May 2025
European biotech: trends to watch in 2025
Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global policies.
- Latest Posts
Best in Biotech 23 May 2025
Finland: Pushing biotech forward in the land of a thousand lakes
Explore seven leading biotech companies driving Finland’s biotech sector forward in precision medicine, immunotherapy, and more.
Podcast 23 May 2025
How generative AI and ‘Photoshop for proteins’ are transforming biopharma R&D
Generative artificial intelligence’s biggest impacts on biotech are still to come. Learn more in our talk with Cradle Therapeutics’s co-founder, Elise de Reus.
News and Trends 21 May 2025
Layoffs in the US: what is going on with genomics companies?
Genomics companies have been slashing jobs and culling programs in the US. Learn about the layoffs that have struck the industry in 2025.
In Depth 21 May 2025
Gene therapy for skin diseases: A field still finding its footing
Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of something more?
Best in Biotech 20 May 2025
Seven lung cancer companies advancing new treatments in 2025
Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to bispecific antibodies.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 19 May 2025
Will Europe become the new home for US researchers affected by policy shifts?
The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding in a move to attract U.S. researchers.
Oncology R&D trends and breakthrough innovations
Explore the latest in oncology R&D with Inpart’s new trends report, featuring emerging technologies, breakthrough innovations, and expert insights shaping the future of cancer research.
Best in Biotech 16 May 2025
Nine promising small molecule drug discovery companies to look out for in 2025
Discover nine small molecule drug discovery companies that have raised funding for their novel medicines in the last year.
Podcast 16 May 2025
Fighting mucopolysaccharidosis type I, a rare disease, by reprogramming B-cells
This week we talk with Immusoft CEO Sean Ainsworth to learn more about his journey in biotechnology and the work that Immusoft is doing in B-cell reprogramming
Expert Advice 15 May 2025
Expert tips to choose the right CDMO for your biotech company
Find out the best way to find the right CDMO for your biotech. Experts shared some advice to help companies through the process.
In Depth 14 May 2025
The stem cell race for Parkinson’s disease: Recent studies show significant promise
Discover how stem cells could be used to treat Parkinson’s disease, as positive early-stage studies in the field show significant promise.
ADVERTISEMENT
